Live from the NIH registry
Studies recruiting near Canton right now
Top 25 of 301 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Cleveland Clinic Mercy Hospital — Canton, Ohio (0.8 mi)
· Sponsor: SWOG Cancer Research Network
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Cleveland Clinic Wooster Family Health and Surgery Center — Wooster, Ohio (29.8 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma
Phase 1
Interventional 168 participants sought
Gabrail Cancer Center Research — Canton, Ohio (0.8 mi)
· Sponsor: OncoNano Medicine, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital Medical Center of Akron — Akron, Ohio (20.5 mi)
· Sponsor: National Cancer Institute (NCI)
Investigations of Reproductive Cancers in Women
Uterine Cancer
N/A
Observational 4,500 participants sought
Summa Health — Akron, Ohio (20.5 mi)
· Sponsor: PinkDx, Inc.
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
Focal Segmental Glomerulosclerosis
N/A
Interventional 35 participants sought
Akron Children's Hospital — Akron, Ohio (20.5 mi)
· Sponsor: Kaneka Medical America LLC
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Yanke Bionics - W Exchange St — Akron, Ohio (20.5 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
Platinum-resistant Ovarian Cancer, Testicular Cancer
Phase 1
Interventional 156 participants sought
Gabrail Cancer Center — Canton, Ohio (0.8 mi)
· Sponsor: Context Therapeutics Inc.
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Aultman Hospital — Canton, Ohio (0.8 mi)
· Sponsor: Duke University
A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
Cognitive Impairment Associated With Schizophrenia (CIAS)
Phase 2
Interventional 150 participants sought
Neuro-Behavioral Clinical Research — North Canton, Ohio (5.0 mi)
· Sponsor: Kynexis B.V.
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
Metastatic Pancreatic Adenocarcinoma
Phase 3
Interventional 480 participants sought
Gabrail Cancer Center Research — Canton, Ohio (0.8 mi)
· Sponsor: Eleison Pharmaceuticals LLC.
The PREDICT Registry:
DCIS, Stage 0 Breast Cancer
N/A
Observational 3,000 participants sought
Cleveland Clinic Akron General — Akron, Ohio (20.5 mi)
· Sponsor: PreludeDx
International Rare Brain Tumor Registry
Astroblastoma, BCOR ITD Sarcoma
N/A
Observational 5,800 participants sought
Akron Children's Hospital — Akron, Ohio (20.5 mi)
· Sponsor: Children's National Research Institute
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
Colonic Neoplasms, Neoplasms, Colon
Phase 3
Interventional 892 participants sought
GSK Investigational Site — Akron, Ohio (20.5 mi)
· Sponsor: GlaxoSmithKline
CLAiR Pivotal Study
No Condition
N/A
Observational 942 participants sought
Diabetes and Endocrine Associates of Stark County — Canton, Ohio (0.8 mi)
· Sponsor: Toku Eyes Ltd
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
Failed or Difficult Intubation, Sequela, Intubation; Difficult
N/A
Observational 150,000 participants sought
Akron Children's Hospital — Akron, Ohio (20.5 mi)
· Sponsor: Children's Hospital of Philadelphia
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma
Phase 3
Interventional 1,450 participants sought
University Hospitals Sharon Health Center — Wadsworth, Ohio (24.2 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Post-Market Domestic (US) and International Data Collection to Assess the Truliant Knee System
Knee Arthroplasty, Total
N/A
Observational 1,000 participants sought
Crystal Clinic — Akron, Ohio (20.5 mi)
· Sponsor: Exactech
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Diabetes and Endocrinology Associates of Stark County Inc /ID# 256751 — Canton, Ohio (0.8 mi)
· Sponsor: AbbVie
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Akron, Ohio (20.5 mi)
· Sponsor: Akero Therapeutics, Inc
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
Type 2 Diabetes
Phase 2
Interventional 300 participants sought
Diabetes & Endocrinology Associates of Stark County, Inc. — Canton, Ohio (0.8 mi)
· Sponsor: Housey Healthcare ULC
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 2
Interventional 240 participants sought
University Hospitals Portage Medical Center — Ravenna, Ohio (25.0 mi)
· Sponsor: NRG Oncology
A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome
Lipidemia, Type 2 Diabetes (T2DM)
Phase 3
Interventional 300 participants sought
Summit Research Group — Munroe Falls, Ohio (23.6 mi)
· Sponsor: NewAmsterdam Pharma
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer
Phase 3
Interventional 1,410 participants sought
Aultman Hospital — Canton, Ohio (0.8 mi)
· Sponsor: Pfizer
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
HR+/HER2- Breast Cancer
Phase 3
Interventional 1,056 participants sought
Gabrail Cancer Center Research — Canton, Ohio (0.8 mi)
· Sponsor: BeOne Medicines